Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective.
Saved in:
| Title: | Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective. |
|---|---|
| Authors: | Wiethoff I; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. i.wiethoff@maastrichtuniversity.nl., Witlox WJA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands., Evers SMAA; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.; Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Centre for Economic Evaluation, Utrecht, The Netherlands., Michels M; Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center, Rotterdam, The Netherlands., Hiligsmann M; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2026 Feb; Vol. 44 (2), pp. 245-259. Date of Electronic Publication: 2025 Nov 20. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41261267 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wiethoff+I%22">Wiethoff I</searchLink>; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. i.wiethoff@maastrichtuniversity.nl.<br /><searchLink fieldCode="AU" term="%22Witlox+WJA%22">Witlox WJA</searchLink>; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Evers+SMAA%22">Evers SMAA</searchLink>; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.; Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Centre for Economic Evaluation, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Michels+M%22">Michels M</searchLink>; Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hiligsmann+M%22">Hiligsmann M</searchLink>; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229212404%22">PharmacoEconomics</searchLink> [Pharmacoeconomics] 2026 Feb; Vol. 44 (2), pp. 245-259. <i>Date of Electronic Publication: </i>2025 Nov 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9212404 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211707690%22">11707690 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoeconomics <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41261267 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40273-025-01564-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 245 Titles: – TitleFull: Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal Perspective. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wiethoff I – PersonEntity: Name: NameFull: Witlox WJA – PersonEntity: Name: NameFull: Evers SMAA – PersonEntity: Name: NameFull: Michels M – PersonEntity: Name: NameFull: Hiligsmann M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-2027 Numbering: – Type: volume Value: 44 – Type: issue Value: 2 Titles: – TitleFull: PharmacoEconomics Type: main |
| ResultId | 1 |
